Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation TCT 2022

TCT 688: An Unfortuante Trifecta: A case of acute myocardial infarction with cardiogenic shock, pericardial tamponade, and worsening hypoxia with right to left shunt after percutaneous LVAD placement.

Presenter: Sana Shaukat

September 18, 2022

Presentation TCT 2022

TCT 343: Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure: EASE HF

Presenter: Saibal Kar

September 18, 2022

Presentation TCT 2022

TCT 342: Early Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure with Preserved and Reduced Ejection Fraction: Latest Results From the Early Feasibility ALLEVIATE-HF Programs

Presenter: Roxana Mehran

September 18, 2022

Presentation TCT 2022

TCT 804: Post-pneumonectomy hypoxia: A Case of intracardiac shunt unmasked by right-sided pneumonectomy and treated percutaneously

Presenter: Adil Bata

September 17, 2022

Presentation TCT 2022

Left Atrial to Coronary Sinus Shunt Therapy In Heart Failure: Early Insights

Presenter: Benjamin Hibbert

September 17, 2022

Presentation TCT 2022

Interatrial Shunting With No Device Left Behind

Presenter: James E. Udelson

September 17, 2022

Presentation TCT 2022

New Insights Into Interatrial Shunting From the REDUCE-LAP II Study

Presenter: Sheldon E. Litwin

September 17, 2022

Presentation TCT 2022

Pulmonary to Venous Shunt for Group 2 PH-HFpEF (NXT™ Rivet)

Presenter: Rob Taft

September 17, 2022

Presentation TCT 2022

The Interventional HF Innovation Landscape: What Is Working and What Is Not!

Presenter: Navin Kapur

September 16, 2022

Presentation TCT 2022

Moving Beyond Pharmacotherapy: The Transformative Role of Devices in HF Treatment

Presenter: William Abraham

September 16, 2022

Presentation TCT 2022

Payer's Perspective

Presenter: Lonny Reisman

September 16, 2022

Presentation TCT 2022

Industry Perspective

Presenter: Philip B. Adamson

September 16, 2022

Presentation TCT 2022

Hospital Perspective

Presenter: Marvin A. Konstam

September 16, 2022

Presentation TVT 2022

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Presenter: Sanjiv Shah

June 10, 2022

RELIEVE HF: Different Patient Selection and Study Design – Should We Expect Different Results?

Presentation TVT 2022

Less Invasive Ventricular Enhancement for HFrEF

Presenter: John Boehmer

June 10, 2022

Presentation TVT 2022

What (Else) Have We Learned From REDUCE-LAP II?

Presenter: Sanjiv Shah

June 10, 2022

Presentation TVT 2022

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

Presenter: Daniel Burkhoff

June 10, 2022

Presentation TVT 2022

The Alleviant No-Implant Interatrial Shunt for HF: The ALLEVIATE HF1 Trial Results

Presenter: Peter S. Fail

June 10, 2022

Presentation THT 2022

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Presenter: JoAnn Lindenfeld

February 02, 2022

Presentation THT 2022

Alleviant Medical Pivotal Study Overview and Next Steps

Presenter: James Udelson

February 02, 2022

Advertisement

TCT 688: An Unfortuante Trifecta: A case of acute myocardial infarction with cardiogenic shock, pericardial tamponade, and worsening hypoxia with right to left shunt after percutaneous LVAD placement.

TCT 343: Evaluation of an Implant Free Interatrial Shunt to Improve Heart Failure: EASE HF

TCT 342: Early Multi-center Clinical Outcomes of a No-Implant Interatrial Shunt for Heart Failure with Preserved and Reduced Ejection Fraction: Latest Results From the Early Feasibility ALLEVIATE-HF Programs

TCT 804: Post-pneumonectomy hypoxia: A Case of intracardiac shunt unmasked by right-sided pneumonectomy and treated percutaneously

Left Atrial to Coronary Sinus Shunt Therapy In Heart Failure: Early Insights

Interatrial Shunting With No Device Left Behind

New Insights Into Interatrial Shunting From the REDUCE-LAP II Study

Pulmonary to Venous Shunt for Group 2 PH-HFpEF (NXT™ Rivet)

The Interventional HF Innovation Landscape: What Is Working and What Is Not!

Moving Beyond Pharmacotherapy: The Transformative Role of Devices in HF Treatment

Payer's Perspective

Industry Perspective

Hospital Perspective

Exercise PVR, A Key Predictor of Benefit of Atrial Shunt Therapy in HFpEF?

Less Invasive Ventricular Enhancement for HFrEF

What (Else) Have We Learned From REDUCE-LAP II?

Overview of the Interatrial Shunt Device Landscape: Conceptual Basis and Devices

The Alleviant No-Implant Interatrial Shunt for HF: The ALLEVIATE HF1 Trial Results

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Alleviant Medical Pivotal Study Overview and Next Steps

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content